 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 1998, 18(21):8692-8699
Selective Activation of G o by D2L
Dopamine Receptors in NS20Y Neuroblastoma Cells
Val J.
Watts1,
Brenda
L.
Wiens1,
Medhane G.
Cumbay1,
Minh N.
Vu1,
Rachael L.
Neve2, and
Kim A.
Neve1
1 Medical Research Service, Veterans Affairs Medical
Center, and Department of Behavioral Neuroscience, Oregon Health
Sciences University, Portland, Oregon 97201, and
2 Department of Genetics, Harvard Medical School, and
McLean Hospital, Belmont, Massachusetts 02178
D2L dopamine receptor activation results in rapid
inhibition and delayed heterologous sensitization of adenylate cyclase
in several host cell types. The D2L dopamine receptor was
stably transfected into NS20Y neuroblastoma cells to examine inhibition and sensitization in a neuronal cell environment and to identify the
particular G-proteins involved. Acute activation of D2L
receptors with the selective D2 agonist quinpirole
inhibited forskolin-stimulated cAMP accumulation, whereas
prolonged incubation (2 hr) with quinpirole resulted in heterologous
sensitization (more than twofold) of forskolin-stimulated cAMP
accumulation in NS20Y-D2L cells. To unambiguously identify
the pertussis toxin (PTX)-sensitive G-proteins responsible for
inhibition and sensitization, we used viral-mediated gene delivery to
assess the ability of genetically engineered PTX-resistant G-proteins
(G i1*, G i2*, G i3*, and
G o*) to rescue both responses after PTX treatment. The
expression and function of individual recombinant G-proteins was
confirmed with Western blotting and inhibition of GTP S-stimulated
adenylate cyclase, respectively. To assess the specificity of
D2L-G coupling, cells were infected with herpes simplex
virus (HSV) recombinants expressing individual PTX-resistant
G-protein subunits and treated with PTX, and quinpirole-induced
responses were measured. Infection of NS20Y-D2L cells with
HSV-G o* rescued both inhibition and sensitization in
PTX-treated cells, whereas infection with HSV-G i1*,
HSV-G i2*, or HSV-G i3* failed to rescue
either response. In summary, the current study provides strong evidence
that the D2L dopamine receptor couples to G o
in neuronal cells, and that this coupling is responsible for both the
acute and subacute effects of D2 receptor activation on
adenylate cyclase activity.
Key words:
dopamine D2L receptors; G i/o; NS20Y neuroblastoma; adenylate cyclase; pertussis toxin; heterologous sensitization
Copyright © 1998 Society for Neuroscience 0270-6474/98/18218692-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
P. M. Lalley
D1/D2-dopamine receptor agonist dihydrexidine stimulates inspiratory motor output and depresses medullary expiratory neurons
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2009;
296(6):
R1829 - R1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lan, Y. Liu, M. I. Bell, V. V. Gurevich, and K. A. Neve
A Dopamine D2 Receptor Mutant Capable of G Protein-Mediated Signaling but Deficient in Arrestin Binding
Mol. Pharmacol.,
January 1, 2009;
75(1):
113 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Lane, B. Powney, A. Wise, S. Rees, and G. Milligan
G Protein Coupling and Ligand Selectivity of the D2L and D3 Dopamine Receptors
J. Pharmacol. Exp. Ther.,
April 1, 2008;
325(1):
319 - 330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Gay, J. D. Urban, D. E. Nichols, G. S. Oxford, and R. B. Mailman
Functional Selectivity of D2 Receptor Ligands in a Chinese Hamster Ovary hD2L Cell Line: Evidence for Induction of Ligand-Specific Receptor States
Mol. Pharmacol.,
July 1, 2004;
66(1):
97 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Clark, R. R. Neubig, and J. R. Traynor
Endogenous Regulator of G Protein Signaling Proteins Suppress G{alpha}o-Dependent, {micro}-Opioid Agonist-Mediated Adenylyl Cyclase Supersensitization
J. Pharmacol. Exp. Ther.,
July 1, 2004;
310(1):
215 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Liapakis, W. C. Chan, M. Papadokostaki, and J. A. Javitch
Synergistic Contributions of the Functional Groups of Epinephrine to Its Affinity and Efficacy at the {beta}2 Adrenergic Receptor
Mol. Pharmacol.,
May 1, 2004;
65(5):
1181 - 1190.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. A. Vortherms and V. J. Watts
Sensitization of Neuronal A2A Adenosine Receptors after Persistent D2 Dopamine Receptor Activation
J. Pharmacol. Exp. Ther.,
January 1, 2004;
308(1):
221 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Holtje, S. Winter, D. Walther, I. Pahner, H. Hortnagl, O. P. Ottersen, M. Bader, and G. Ahnert-Hilger
The Vesicular Monoamine Content Regulates VMAT2 Activity through Galpha q in Mouse Platelets. EVIDENCE FOR AUTOREGULATION OF VESICULAR TRANSMITTER UPTAKE
J. Biol. Chem.,
April 25, 2003;
278(18):
15850 - 15858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Hooks, G. L. Waldo, J. Corbitt, E. T. Bodor, A. M. Krumins, and T. K. Harden
RGS6, RGS7, RGS9, and RGS11 Stimulate GTPase Activity of Gi Family G-proteins with Differential Selectivity and Maximal Activity
J. Biol. Chem.,
March 14, 2003;
278(12):
10087 - 10093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Watts
Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase
J. Pharmacol. Exp. Ther.,
July 1, 2002;
302(1):
1 - 7.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Straiker, C. R. Borden, and J. M. Sullivan
G-Protein alpha Subunit Isoforms Couple Differentially to Receptors that Mediate Presynaptic Inhibition at Rat Hippocampal Synapses
J. Neurosci.,
April 1, 2002;
22(7):
2460 - 2468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Watts, R. Taussig, R. L. Neve, and K. A. Neve
Dopamine D2 Receptor-Induced Heterologous Sensitization of Adenylyl Cyclase Requires Galpha s: Characterization of Galpha s-Insensitive Mutants of Adenylyl Cyclase V
Mol. Pharmacol.,
December 1, 2001;
60(6):
1168 - 1172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Cumbay and V. J. Watts
Heterologous Sensitization of Recombinant Adenylate Cyclases by Activation of D2 Dopamine Receptors
J. Pharmacol. Exp. Ther.,
June 1, 2001;
297(3):
1201 - 1209.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Jiang, K. Spicher, G. Boulay, Y. Wang, and L. Birnbaumer
Most central nervous system D2 dopamine receptors are coupled to their effectors by Go
PNAS,
March 1, 2001;
(2001)
51632598.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. D. Mayfield and N. R. Zahniser
Dopamine D2 Receptor Regulation of the Dopamine Transporter Expressed in Xenopus laevis Oocytes Is Voltage-Independent
Mol. Pharmacol.,
January 1, 2001;
59(1):
113 - 121.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. Antonelli, F. Bernasconi, Y. H. Wong, and L. Vallar
Activation of B-Raf and Regulation of the Mitogen-activated Protein Kinase Pathway by the Go alpha chain
Mol. Biol. Cell,
April 1, 2000;
11(4):
1129 - 1142.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Liapakis, J. A. Ballesteros, S. Papachristou, W. C. Chan, X. Chen, and J. A. Javitch
The Forgotten Serine. A CRITICAL ROLE FOR Ser-2035.42 IN LIGAND BINDING TO AND ACTIVATION OF THE beta 2-ADRENERGIC RECEPTOR
J. Biol. Chem.,
November 22, 2000;
275(48):
37779 - 37788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jiang, K. Spicher, G. Boulay, Y. Wang, and L. Birnbaumer
Most central nervous system D2 dopamine receptors are coupled to their effectors by Go
PNAS,
March 13, 2001;
98(6):
3577 - 3582.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|